Luis Paz-Ares Rodríguez-rekin lankidetzan egindako argitalpenak (4)

2006

  1. Randomized study of cefepime versus ceftazidime plus amikacin in patients with solid tumors treated with high dose chemotherapy (HDC) and peripheral blood stem cell support (PBSCS) with febrile neutropenia

    Clinical and Translational Oncology, Vol. 8, Núm. 12, pp. 889-895

2001

  1. Granulocyte colony-stimulating factor in the treatment of high-risk febrile neutropenia: A multicenter randomized trial

    Journal of the National Cancer Institute, Vol. 93, Núm. 1, pp. 31-38

1997

  1. Patient selection in high-dose chemotherapy trials: Relevance in high- risk breast cancer

    Journal of Clinical Oncology, Vol. 15, Núm. 10, pp. 3178-3184

  2. Phase I/II study of paclitaxel/cisplatin as first-line therapy for locally advanced head and neck cancer

    Seminars in Oncology, Vol. 24, Núm. 6 SUPPL. 19